Pharmaceutical Sciences Seminar Series presents “Identifying in vivo proteostatic control mechanisms: towards an intervention for Alzheimer’s, cancer, and even aging.”
John C. Price, Ph.D.
Assistant Professor of Chemistry and Biochemistry
Brigham Young University
WHEN: Friday, Nov. 30, 2018 from noon to 1 p.m.
The quality and concentration of each protein in each cell of our bodies is stable because of the concerted regulation of synthesis, folding, and degradation. This state (proteostasis) must be maintained throughout the lifetime of the organism. Alzheimer’s, diabetes, cancer, and even aging are promoted by loss of proteostasis. We are identifying how proteostasis controls are modulated to promote health or disease.
-Submitted by Cheri Harris